Browse Articles by David Penn



How to Sell a Stock Short: Sprint Nextel

David Penn - February 08, 2012
S
Data-driven trading helps active investors spot opportunities in stocks in and out of earnings season. Read More >>

The Intel Pullback as Pitstop: Three Down, Six Up

David Penn - February 06, 2012
INTC
Intel's recent run to new highs was prompted by a three-day pullback around the market's January three-day holiday. Read More >>

Big Weekly Winners in Stocks: Swing Trading with PowerRatings

David Penn - February 05, 2012
MU , FCF , BLX
This week's Big Weekly Winners includes top-performing, top-rated stocks like Micron Technology and First Commonwealth Financial. Read More >>

ETF of the Week: PowerShares High Yield Equity Dividend Achievers Portfolio ETF

David Penn - February 05, 2012
PEY
Want to buy low and sell high? Let PowerRatings be your guide to buying weakness and selling strength when it comes to trading ETFs. Read More >>

Stock of the Week: Buying the Selling in Radvision

David Penn - February 05, 2012
RVSN
A truly "rad" performance from Radvision follows a major ratings upgrade to "consider buying" levels. Read More >>

Trading A Double Shot of Peet's Coffee & Tea

David Penn - January 30, 2012
PEET
While the financial news media was focused on Starbucks and Green Mountain Coffee Roasters, subscribers to 7 Stocks You Need to Know were paying no less attention to the pullback in Peet's Coffee and Tea. Read More >>

Big Weekly Winners: Swing Trading with PowerRatings

David Penn - January 29, 2012
MITI , ACHN , MDVN
Biotechnology stocks continue to be big winners for short-term traders and active investors using PowerRatings to help find the best stocks to trade every day. Read More >>

Stock of the Week: American Public Education

David Penn - January 29, 2012
APEI
A four-day pullback into oversold territory last week helped alert short-term traders to an opportunity in shares of APEI. Read More >>

ETF of the Week: S&P Biotech SPDRS ETF

David Penn - January 29, 2012
XBI
The S&P Biotech SPDRS ETF is one solution to trading the single-stock volatility of individual biotech companies. Read More >>

Marvell Makes Good: Nearly 9% in Less Than a Week

David Penn - January 25, 2012
MRVL
A five-day pullback set up an opportunity for buyers of weakness in this semiconductor stock. Read More >>